Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site

NCT ID: NCT03539692

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-10

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a protocol for prescreening of participants who would like to be in clinical studies in our Center at Stanford.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Food Allergy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any individual with possible food allergy (as per their clinical history) who is interested in performing the gold standard food challenge for diagnosis.

Exclusion Criteria

* Any individual who does not consent
* Any individual who is currently taking oral steroids
* Any individual with moderate to severe asthma (FEV1\<80%)
Minimum Eligible Age

1 Week

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role collaborator

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sayantani B. Sindher

Clinical Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sayantani Sindher, MD

Role: PRINCIPAL_INVESTIGATOR

Stanford University, SNP Center for Food Allergy and Asthma Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Sean N. Parker Center for Allergy and Asthma Research, Stanford University

Palo Alto, California, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

SNP Center Inquiry

Role: CONTACT

650-521-7237

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

SNP Center Inquiry

Role: primary

650-521-7237

References

Explore related publications, articles, or registry entries linked to this study.

Purington N, Chinthrajah RS, Long A, Sindher S, Andorf S, O'Laughlin K, Woch MA, Scheiber A, Assa'ad A, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Galli SJ, Desai M, Nadeau KC. Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges. Front Immunol. 2018 Sep 21;9:2057. doi: 10.3389/fimmu.2018.02057. eCollection 2018.

Reference Type DERIVED
PMID: 30298065 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1UM1AI130839-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

FY20ITN384

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

5U19AI104209-07

Identifier Type: NIH

Identifier Source: secondary_id

View Link

5UM1AI82034-02

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

34738

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Allergy Experience Study
NCT03513965 COMPLETED NA
Food Oral Immunotherapy for Peanut Allergy
NCT04222491 ENROLLING_BY_INVITATION PHASE2
Microbiota and Allergy
NCT04750980 COMPLETED
Tolerance Following Peanut Oral Immunotherapy
NCT01750879 COMPLETED PHASE1/PHASE2